A human β-cell line for transplantation therapy to control type 1 diabetes

M Narushima, N Kobayashi, T Okitsu, Y Tanaka… - Nature …, 2005 - nature.com
M Narushima, N Kobayashi, T Okitsu, Y Tanaka, SA Li, Y Chen, A Miki, K Tanaka, S Nakaji…
Nature biotechnology, 2005nature.com
A human pancreatic β-cell line that is functionally equivalent to primary β-cells has not been
available. We established a reversibly immortalized human β-cell clone (NAKT-15) by
transfection of primary human β-cells with a retroviral vector containing simian virus 40 large
T-antigen (SV40T) and human telomerase reverse transcriptase (hTERT) cDNAs flanked by
paired loxP recombination targets, which allow deletion of SV40T and TERT by Cre
recombinase. Reverted NAKT-15 cells expressed β-cell transcription factors (Isl-1, Pax 6 …
Abstract
A human pancreatic β-cell line that is functionally equivalent to primary β-cells has not been available. We established a reversibly immortalized human β-cell clone (NAKT-15) by transfection of primary human β-cells with a retroviral vector containing simian virus 40 large T-antigen (SV40T) and human telomerase reverse transcriptase (hTERT) cDNAs flanked by paired loxP recombination targets, which allow deletion of SV40T and TERT by Cre recombinase. Reverted NAKT-15 cells expressed β-cell transcription factors (Isl-1, Pax 6, Nkx 6.1, Pdx-1), prohormone convertases 1/3 and 2, and secretory granule proteins, and secreted insulin in response to glucose, similar to normal human islets. Transplantation of NAKT-15 cells into streptozotocin-induced diabetic severe combined immunodeficiency mice resulted in perfect control of blood glucose within 2 weeks; mice remained normoglycemic for longer than 30 weeks. The establishment of this cell line is one step toward a potential cure of diabetes by transplantation.
nature.com